相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
Hong-Yan Cai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells
Begona Canovas et al.
CANCER CELL (2018)
New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules
L. De Matteis et al.
CHEMICAL ENGINEERING JOURNAL (2018)
Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS
Katherine L. Gibbs et al.
CELL DEATH & DISEASE (2018)
Suppression of Lipopolysaccharide-Induced Neuroinflammation by Morin via MAPK, PI3K/Akt, and PKA/HO-1 Signaling Pathway Modulation
Ji-Sun Jung et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles
Ejaj Ahmad et al.
NANOSCALE (2017)
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways
M. Perluigi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Intranasal Administration of Chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease
O. Gartziandia et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration
Matthias Van Woensel et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting
Laura De Matteis et al.
MARINE DRUGS (2016)
Single App knock-in mouse models of Alzheimer's disease
Takashi Saito et al.
NATURE NEUROSCIENCE (2014)
MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition
David M. Taylor et al.
JOURNAL OF NEUROSCIENCE (2013)
Discovery and Characterization of Atropisomer PH-797804, a p38 MAP Kinase Inhibitor, as a Clinical Drug Candidate
Li Xing et al.
CHEMMEDCHEM (2012)
The Rostral Migratory Stream Plays a Key Role in Intranasal Delivery of Drugs into the CNS
Robert A. Scranton et al.
PLOS ONE (2011)
Biodegradation, biodistribution and toxicity of chitosan
T. Kean et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation
Heidi R. Hope et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process
Regina G. Kelmann et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
P38 MAP-Kinases pathway regulation, function and role in human diseases
Ana Cuenda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts
J Westra et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
分享论文
